{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:21:25Z","timestamp":1778656885258,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG5220"],"award-info":[{"award-number":["IG5220"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG13466"],"award-info":[{"award-number":["IG13466"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG15282"],"award-info":[{"award-number":["IG15282"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003980","name":"Istituto Toscano Tumori","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.stemcr.2018.08.016","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T10:39:42Z","timestamp":1537439982000},"page":"929-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells"],"prefix":"10.1016","volume":"11","author":[{"given":"Ignazia","family":"Tusa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Cheloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Poteti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Gozzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoc Ho","family":"DeSouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Rovida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Persio","family":"Dello Sbarba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2018.08.016_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-3083.1996.d01-84.x","article-title":"Characterization of a human basophil-like cell line (LAMA-84)","volume":"44","author":"Blom","year":"1996","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.embor.7400316","article-title":"Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival","volume":"6","author":"Buschbeck","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.stemcr.2018.08.016_bib3","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1182\/blood-2004-08-2985","article-title":"Multifunctional role of Erk5 in multiple myeloma","volume":"105","author":"Carvajal-Vergara","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.18632\/oncotarget.692","article-title":"All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib","volume":"3","author":"Cassuto","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.stemcr.2018.08.016_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","article-title":"Targeting chronic myeloid leukemia stem cells with the\u00a0hypoxia-inducible factor inhibitor acriflavine","volume":"130","author":"Cheloni","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib6","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1126\/science.287.5459.1804","article-title":"Hematopoietic stem cell quiescence maintained by p21cip1\/waf1","volume":"287","author":"Cheng","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2018.08.016_bib7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/81335","article-title":"Stem cell repopulation efficiency but not pool size is governed by p27(kip1)","volume":"6","author":"Cheng","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2018.08.016_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0006-3495(01)75733-5","article-title":"Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models","volume":"81","author":"Chow","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.stemcr.2018.08.016_bib9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V82.7.2031.2031","article-title":"The role of hypoxia in the maintenance of hematopoietic stem cells","volume":"82","author":"Cipolleschi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.leu.2401744","article-title":"The expansion of murine bone marrow cells preincubated in hypoxia as an in\u00a0vitro indicator of their marrow-repopulating ability","volume":"14","author":"Cipolleschi","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.stemcr.2018.08.016_bib11","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.2174\/1381612811319300006","article-title":"The culture-repopulating ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells","volume":"19","author":"Cipolleschi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.stemcr.2018.08.016_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stemcr.2018.08.016_bib13","doi-asserted-by":"crossref","first-page":"33016","DOI":"10.18632\/oncotarget.9108","article-title":"Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects","volume":"7","author":"Culen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.stemcr.2018.08.016_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1172\/JCI17669","article-title":"Expansion of human SCID-repopulating cells under hypoxic conditions","volume":"112","author":"Danet","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stemcr.2018.08.016_bib15","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1242\/jcs.070516","article-title":"Multisite phosphorylation of Erk5 in mitosis","volume":"123","author":"D\u00edaz-Rodr\u00edguez","year":"2010","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.stemcr.2018.08.016_bib16","first-page":"37","article-title":"MEK5\/ERK5\u00a0pathway: the first fifteen years","volume":"1825","author":"Drew","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.stemcr.2018.08.016_bib17","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stemcr.2018.08.016_bib18","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","article-title":"Hematopoietic stem cells: concepts, definitions, and the new reality","volume":"125","author":"Eaves","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcp.21908","article-title":"The hematopoietic stem cell niche: low in oxygen but a nice place to be","volume":"222","author":"Eliasson","year":"2010","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/MCB.22.1.270-285.2002","article-title":"Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2","volume":"22","author":"Esparis-Ogando","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/stem.769","article-title":"Concise review: cancer stem cells and minimal residual disease","volume":"30","author":"Ghiaur","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2018.08.016_bib22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.leu.2404224","article-title":"Hypoxia suppresses BCR\/Abl and selects Imatinib-insensitive progenitors within clonal CML population","volume":"20","author":"Giuntoli","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.stemcr.2018.08.016_bib23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1634\/stemcells.2006-0637","article-title":"Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukaemia cells","volume":"25","author":"Giuntoli","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2018.08.016_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3324\/haematol.2010.029082","article-title":"Glucose availability in hypoxia regulates the selection of chronic myeloid leukaemia progenitor subsets with different resistance to imatinib-mesylate","volume":"96","author":"Giuntoli","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.stemcr.2018.08.016_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in\u00a0vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2006.11.047","article-title":"Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases","volume":"128","author":"Grimmler","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2018.08.016_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/cdd.2010.85","article-title":"Very low oxygen concentration (0.1%) reveals two FDCP-Mix cell subpopulations that differ by their cell cycling, differentiation and p27KIP1 expression","volume":"18","author":"Guitart","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.stemcr.2018.08.016_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.2004-0351","article-title":"Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells","volume":"24","author":"Hermitte","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.stemcr.2018.08.016_bib29","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib30","doi-asserted-by":"crossref","first-page":"e0117914","DOI":"10.1371\/journal.pone.0117914","article-title":"Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription","volume":"10","author":"Honda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2018.08.016_bib31","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Hu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2018.08.016_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-472X(01)00765-2","article-title":"Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells","volume":"30","author":"Ivanovic","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/27234","article-title":"Bmk1\/Erk5 is required for cell proliferation induced by epidermal growth factor","volume":"395","author":"Kato","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2018.08.016_bib34","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.ajpath.2013.08.014","article-title":"ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation","volume":"183","author":"Kim","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/stem.5530010205","article-title":"Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis","volume":"1","author":"Kubonishi","year":"1983","journal-title":"Int. J. Cell Cloning"},{"key":"10.1016\/j.stemcr.2018.08.016_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4161\/cc.11.4.19211","article-title":"MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5\/cyclin D1 signaling","volume":"11","author":"Lai","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.stemcr.2018.08.016_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.stem.2008.09.005","article-title":"Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity","volume":"3","author":"Laurenti","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2018.08.016_bib38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.1995.2189","article-title":"Primary structure of BMK1: a new mammalian map kinase","volume":"213","author":"Lee","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.stemcr.2018.08.016_bib39","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity","volume":"189","author":"Li","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.stemcr.2018.08.016_bib40","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.1609019113","article-title":"ERK5 kinase activity is dispensable for cellular immune response and proliferation","volume":"113","author":"Lin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2018.08.016_bib41","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/15384101.2015.1120915","article-title":"Tumor cells with KRAS or BRAF mutations or ERK5\/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation","volume":"15","author":"Lochhead","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.stemcr.2018.08.016_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre STop IMatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib44","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/sj.onc.1210963","article-title":"Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer","volume":"27","author":"McCracken","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2018.08.016_bib45","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.cellsig.2012.07.007","article-title":"ERK5: structure, regulation and function","volume":"24","author":"Nithianandarajah-Jones","year":"2012","journal-title":"Cell Signal."},{"key":"10.1016\/j.stemcr.2018.08.016_bib46","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2018.08.016_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-60761-058-8_15","article-title":"CML mouse model in translational research","volume":"602","author":"Peng","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib48","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.cellsig.2012.08.001","article-title":"The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs)","volume":"24","author":"Perez-Madrigal","year":"2012","journal-title":"Cell Signal."},{"key":"10.1016\/j.stemcr.2018.08.016_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0950-3536(97)80019-4","article-title":"Stem cells: characterization and measurement","volume":"10","author":"Ploemacher","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib50","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2007-07-102061","article-title":"Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets","volume":"110","author":"Rix","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib51","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.4049\/jimmunol.180.6.4166","article-title":"ERK5\/BMK1 is indispensable for optimal colony stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion","volume":"180","author":"Rovida","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib52","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/gutjnl-2014-306761","article-title":"The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma","volume":"64","author":"Rovida","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.stemcr.2018.08.016_bib53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2018.08.016_bib54","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.drudis.2016.06.010","article-title":"The MEK5\/ERK5 signalling pathway in cancer: a promising novel therapeutic target","volume":"21","author":"Sim\u00f5es","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.stemcr.2018.08.016_bib55","doi-asserted-by":"crossref","first-page":"31985","DOI":"10.18632\/oncotarget.5155","article-title":"The complex metabolic network gearing the G1\/S transition in leukemic stem cells: hints to a rational use of antineoplastic agents","volume":"6","author":"Stivarou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.stemcr.2018.08.016_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2014.05.011","article-title":"XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism","volume":"351","author":"Sureban","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.stemcr.2018.08.016_bib57","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood.V74.5.1563.1563","article-title":"Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in\u00a0vitro","volume":"74","author":"Sutherland","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.stemcr.2018.08.016_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2008.09.087","article-title":"Identification of pharmacological inhibitors of the MEK5\/ERK5 pathway","volume":"377","author":"Tatake","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.stemcr.2018.08.016_bib59","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41388-018-0164-9","article-title":"ERK5 is activated by oncogenic BRAF and promotes melanoma growth","volume":"37","author":"Tusa","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2018.08.016_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature07618","article-title":"Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells","volume":"457","author":"Viale","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2018.08.016_bib61","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jcp.24513","article-title":"ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells","volume":"229","author":"Wang","year":"2014","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcp.2015.12.002","article-title":"Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to Imatinib by regulation of cell cycle and apoptosis-associated members via NF-\u03baB and ERK5 signaling pathway","volume":"99","author":"Wang","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib63","first-page":"1","article-title":"Sox9-induced chondrogenesis in mesenchymal stem cells was mediated by ERK5 signal pathway","volume":"62","author":"Wang","year":"2016","journal-title":"Cell Mol. Biol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib64","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.celrep.2016.07.033","article-title":"Erk5 is a key regulator of naive-primed transition and embryonic stem cell identity","volume":"16","author":"Williams","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2018.08.016_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stemcr.2018.08.016_bib66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ccr.2010.08.008","article-title":"Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein","volume":"18","author":"Yang","year":"2010","journal-title":"Cancer Cell"}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671118303606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671118303606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T09:17:41Z","timestamp":1571908661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671118303606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213671118303606"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2018.08.016","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2018.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}